CAS: 17325-26-7; Methyl 1H-Imidazole-5-Carboxylate

相似化合物

127607-71-0 1072-84-0 3034-50-2

上下游产品

CAS号67-56-1 甲醇 | CAS号1072-84-0 1H-咪唑-4-甲酸 | CAS号186581-53-3 重氮甲烷 | CAS号31458-33-0 5-甲氧基嘧啶 | CAS号1093261-46-1 5-溴-1H-咪唑-4-羧酸甲酯 | CAS号18329-78-7 1H-咪唑-5-碳酰肼 | CAS号18438-41-0 3-(1,2,3,4-四氢萘基... | CAS号53525-65-8 咪唑并[1,5-a:1',5'... | CAS号149096-32-2 (9ci)-1-丙基-1H-咪... | CAS号26832-08-6 1H-咪唑-4-甲酰胺 | CAS号1150618-50-0 methyl 1-propan... | CAS号73941-33-0 1-苄基-1H-咪唑-5-羧酸甲酯 | CAS号74294-73-8 methyl 1-benzyl... | CAS号76074-88-9 1-三苯甲基-1H-咪唑-4-羧酸甲酯

Methyl (Z)-3-(Tetrazol-1-yl)Propenoate 以 乙醇 用作溶剂,化学反应 2.5H,反应生成咪唑-4-甲酸甲酯
参考文献:Casey,Michael; Moody,Christopher J.; Rees,Charles W.,Journal Of The Chemical Society. Perkin Transactions I,1985,P. 741-746
标题:Casey,Michael; Moody,Christopher J.; Rees,Charles W.,Journal Of The Chemical Society. Perkin Transactions I,1985,P. 741-746

专利信息

专利号:US-2021085684-A1
优先权日:2016-07-06
标 题:Pde9 inhibitors for treatment of peripheral diseases
发明人：SVENSTRUP NIELS; PARACHIKOVA ANNA I; MCARTHUR JAMES
权利人:IMARA INC
摘要:The present invention relates to PDE9 inhibitors, their synthesis, and their use for treatment of benign prostate hyperplasia, beta thalassemia, and sickle cell disease.

专利号:CN-217188971-U
优先权日:2022-01-24
标 题 :A kind of constant temperature stirring device for synthesis of imidazole-4-methyl carboxylate

专利号:US-2541924-A
优先权日:1948-09-17
标 题 :Synthesis of substituted imidazoles
发明人：JONES REUBEN G
权利人:LILLY CO ELI

专利号:HU-T78019-A
优先权日:1995-03-31
标 题 :A method for the synthesis of substituted nitrogen-containing heterocyclic compounds

专利号:US-2008200475-A1
优先权日:2005-03-28
标题:4-Piperazinothieno[2,3-D] Pyrimidine Compounds As Platelet Aggregation Inhibitors
发明人：ENNIS MICHAEL DALTON; KORTUM STEVEN WADE; TENBRINK RUTH ELIZABETH
权利人:PFIZER
摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I: (I) wherein A 1 , A 2 , A 3 , A 4 , A 5 , A 6 , A 7 , A 8 , X 4 , X 6 , R 2a , R x , R 4 , R 5 , and R 6 are as defined in the detailed description of the invention. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

专利号:US-2009270431-A1
优先权日:2005-10-19
标 题 :Cyclopentenol Nucleoside Compounds Intermediates for their Synthesis and Methods of Treating Viral Infections
发明人：CHU DAVID C K; CHO JONG HYUN; KIM HYO-JOONG
权利人:UNIV GEORGIA RES FOUND
摘要:The present invention relates to compounds according to the structure (I), Where B is formula (Ia), formula (Ib) or formula (Ic); A is H, OR 2 or halogen (F, Cl, Br, I, preferably F or Br, more preferably F); A′ is H, OR2 or halogen (F, Cl, Br, I, preferably F or Br, more preferably F); A″ is H or OR 1 , with the proviso that when A′ is OR, A is H; and when A is OR 2 , A′ is H; X is C—R 3 or N; Y is C—R 3 or N; preferably X or Y is N and X and Y are not both simultaneously N; R 3 is H or C 1 -C 3 alkyl; D is H or NHR 2 ; E is absent or H; G is O or NHR 2 ; J is N or C—R 4 ; K is N or C—H; R 4 is H, halogen (F, Cl, Br, I), CN, —C(â•?O)NH 2 , NH 2 , NO 2 , —Câ•?C—H (cis or trans) or —C≡C—H; R a is H or CH 3 ; Each R 1 is independently H, an acyl group, a C 1 -C 20 alkyl or ether group, a phosphate, diphosphate, triphosphate, phosphodiester group; Each R 2 is independently H, an acyl group, a C 1 -C 20 alkyl or ether group;and Pharmaceutically acceptable salts, solvates or polymorphs thereof.